InvestSMART

Platinum International Health Sciences - Managed Fund

Fund Objective
The Fund primarily invests in health care companies listed on securities markets around the world. It invests in companies engaged in many aspects of providing products and services to the health care industry such as biotechnology, pharmaceuticals, diagnostics, laboratory technologies, distribution, hospitals and nursing care, health insurance and the provision of information technology to such companies.
Fund Strategy
The Fund primarily invests in health care companies listed on securities markets around the world. It invests in companies engaged in many aspects of providing products and services to the health care industry such as biotechnology, pharmaceuticals, diagnostics, laboratory technologies, distribution, hospitals and nursing care, health insurance and the provision of information technology to such companies.

Fund Performance Comparison

Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.

{{ fund.name }}
Peers
Benchmark ({{ fund.benchmark.name }})
{{ fund.model.name }}
The performance of the peers is calculated as the total of the performance for each time period for all the funds in the peer group, divided by the number of funds in the peer group.

Fees Comparison

{{ fund.mer | number:2 }}
% p.a.
{{ fund.name }}
{{ modelPortfolio.mer * 100 | number:2 }}
% p.a.
{{ modelPortfolio.name }}
{{ fund.benchmark.peers.mer * 100 | number:2 }}
% p.a.
Average of peers ({{ fund.benchmark.peers.peerCount }})
NOTE: Fee data has been provided by Morningstar, it may not include all costs being charged on your investment such as platform and adviser fees. You should check your fund manager or adviser statements to find out the exact fees you are being charged. Peers are funds that use the same benchmark in the Morningstar database.
Upsell Banner

Fund performance

  1M 3M 6M 1Y p.a. 2Y p.a. 3Y p.a. 5Y p.a. 10Y p.a.
Total return -3.83% -3.1% 6.54% 43.47% 12.47% 11.59% 2.51% 10.4%
Growth return 2.41% -4% 23.26% 48.77% 10.12% 15.47% 0.28% 3.45%
Income return -6.24% 0.9% -16.72% -5.3% 2.35% -3.88% 2.23% 6.95%
As at 30 Apr 2026. Returns for periods greater than 1 year are annualised. All figures are percentages.

Asset Allocation

Platinum International Health Sciences
Australian Equities
10.34%
International Equities
87.20%
Cash
2.46%

General Information

Fund Details
Type Description
Platinum International Health Sciences
Platinum Asset Management
PLA0005AU
Not Rated
Unknown
5 Nov 2003
$204.3 million (as at 31 Jan 2026)
$2.6911 (as at 30 Apr 2026)
$2.6831 (as at 30 Apr 2026)
Open
Offer information
Type Description
MER 1.35% (as at 31 Mar 2026)
Indirect Cost Ratio (ICR) 1.35% (as at 30 Jun 2025)
Minimum initial investment $10,000.00
Minimum additional investments
Minimum redemption amount $10,000.00

Top 10 holdings (as at 31 Mar 2026)

Holding (as at 31 Mar 2026) Type % of Portfolio
Imricor Medical Systems Inc Chess Depository Interest 5.67%
Login now to view the complete list of holdings.
Your guide to next steps

Dealing with a struggling fund? What to Do and Look For

Your managed fund switching checklist. Is fear of capital gains tax holding you back?
Your managed fund switching checklist. Is fear of capital gains tax holding you back?
The Great Investment Fee Scam is hiding in plain sight. And it's ripping us all off.
The Great Investment Fee Scam is hiding in plain sight. And it's ripping us all off.
Guide to tidying up your Portfolio Manager holdings
Guide to tidying up your Portfolio Manager holdings

FAQs about the Platinum International Health Sciences

The objective of the Platinum International Health Sciences managed fund is The Fund primarily invests in health care companies listed on securities markets around the world. It invests in companies engaged in many aspects of providing products and services to the health care industry such as biotechnology, pharmaceuticals, diagnostics, laboratory technologies, distribution, hospitals and nursing care, health insurance and the provision of information technology to such companies.

The strategy of the Platinum International Health Sciences managed fund is The Fund primarily invests in health care companies listed on securities markets around the world. It invests in companies engaged in many aspects of providing products and services to the health care industry such as biotechnology, pharmaceuticals, diagnostics, laboratory technologies, distribution, hospitals and nursing care, health insurance and the provision of information technology to such companies.

The APIR code of the Platinum International Health Sciences managed fund is PLA0005AU.

Platinum International Health Sciences’s total return last month was -3.83%. This was made up of a growth return of 2.41% and an income return of -6.24%. These returns were calculated as at 30 Apr 2026.

Platinum International Health Sciences’s total return for the last three months was -3.1%. This was made up of a growth return of -4% and an income return of 0.9%%. These returns were calculated as at 30 Apr 2026.

Platinum International Health Sciences’s one-year total return is 43.47%. This was made up of a growth return of 48.77% and an income return of -5.3%. These returns were calculated as at 30 Apr 2026.

Platinum International Health Sciences’s one-year total return is 11.59%. This was made up of a growth return of 15.47% and an income return of -3.88%. These returns were calculated as at 30 Apr 2026.

The asset allocation of the Platinum International Health Sciences managed fund is :

Australian Equities
10.34%
International Equities
87.20%
Cash
2.46%

The Responsible Entity for the Platinum International Health Sciences managed fund is Platinum Asset Management.

As at 31 Jan 2026, the size of the Platinum International Health Sciences managed fund was $204.3 million.

The Platinum International Health Sciences managed fund has an inception date of 5 Nov 2003.

The current entry price of the Platinum International Health Sciences managed fund is $2.6911 per unit and the current exit price is $2.6831 per unit (as at 30 Apr 2026).

The current exit price of the Platinum International Health Sciences managed fund is $2.6831 per unit and the current entry price is $2.6911 per unit (as at 30 Apr 2026).

The minimum initial investment amount for the Platinum International Health Sciences managed fund is $10,000. Minimum additional investment is $0.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.